liposomal glutathione bioavailability human studies liposomal glutathione bioavailability clinical studies A Targeted Metabolomic Assessment of Oral Glutathione Bioavailability and Safety in Humans: A Randomized Crossover Clinical Trial-com Liposomal liposomal glutathione clinical study bioavailability

It is sold only as a research-use-only chemical and is not intended for human consumption

BPC-157 is a 15amino acid peptide originally identified in gastric compounds

The compound has a short circulating half-life of two to three hours, with most physiological effects mediated downstream through insulin-like growth factor 1

Preclinical trials conducted on rats demonstrate measurable improvements in transected tendon reattachment and Achilles tendon rupture models, though human clinical data remain limited

It can reduce weight by up to 24% in only 48 weeks, compared to tirzepatide, which reduced weight by 20.9% after 72 weeks

Glutathione may also help manage symptoms of autoimmune diseases and psoriasis by reducing oxidative stress and inflammation